Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Ferguson
FERG
|
$740M |
| 2 |
Uber
UBER
|
$498M |
| 3 |
DexCom
DXCM
|
$449M |
| 4 |
Meta Platforms (Facebook)
META
|
$312M |
| 5 |
Autodesk
ADSK
|
$305M |
Top Sells
| 1 |
Salesforce
CRM
|
$1.28B |
| 2 |
Apple
AAPL
|
$916M |
| 3 |
PayPal
PYPL
|
$610M |
| 4 |
Bristol-Myers Squibb
BMY
|
$477M |
| 5 |
Accenture
ACN
|
$391M |
Sector Composition
| 1 | Technology | 30.51% |
| 2 | Healthcare | 19.12% |
| 3 | Consumer Discretionary | 11.48% |
| 4 | Financials | 10.31% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Labcorp
LH
$22.9B
| $80.6M | 0.04% |
367,974
-133,547
| -27% | -$29.3M |
|
427
UDR
UDR
$12.9B
| $80.4M | 0.04% |
1,834,148
+313,150
| +21% | +$13.7M |
|
|
AQUA
428
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $79.4M | 0.04% |
3,017,497
+1,115,404
| +59% | +$29.3M |
|
|
DRE
429
DELISTED
Duke Realty Corp.
DRE
| $79.3M | 0.04% |
1,890,091
+398,534
| +27% | +$16.7M |
|
430
Innospec
IOSP
$2.13B
| $78.6M | 0.04% |
765,854
-40,195
| -5% | -$4.13M |
|
431
Pultegroup
PHM
$27.2B
| $78.3M | 0.04% |
1,492,207
-114,842
| -7% | -$6.02M |
|
432
Consolidated Edison
ED
$35.3B
| $77.9M | 0.04% |
1,041,646
-571,096
| -35% | -$42.7M |
|
433
Dell
DELL
$85.7B
| $77.5M | 0.04% |
1,735,575
+1,613,452
| +1,321% | +$72.1M |
|
|
MGP
434
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $77.2M | 0.04% |
2,363,686
+3,239
| +0.1% | +$106K |
|
|
VER
435
DELISTED
VEREIT, Inc.
VER
| $76.6M | 0.04% |
1,981,701
+794,665
| +67% | +$30.7M |
|
436
Essex Property Trust
ESS
$17B
| $76.3M | 0.03% |
280,640
+46,100
| +20% | +$12.5M |
|
437
Encompass Health
EHC
$12.5B
| $76.2M | 0.03% |
1,168,360
+135,058
| +13% | +$8.8M |
|
438
General Mills
GIS
$26.5B
| $75.9M | 0.03% |
1,237,834
-1,303,756
| -51% | -$79.9M |
|
439
SBA Communications
SBAC
$21B
| $75.8M | 0.03% |
273,161
+58,358
| +27% | +$16.2M |
|
440
Arrowhead Research
ARWR
$3.87B
| $75.6M | 0.03% |
1,140,313
-5,130
| -0.4% | -$340K |
|
441
Royal Bank of Canada
RY
$206B
| $75.5M | 0.03% |
818,301
+33,223
| +4% | +$3.06M |
|
442
Emcor
EME
$28.7B
| $75.2M | 0.03% |
670,206
-214,052
| -24% | -$24M |
|
443
Seres Therapeutics
MCRB
$165M
| $75.1M | 0.03% |
182,397
+50,133
| +38% | +$20.6M |
|
444
Moody's
MCO
$89.6B
| $74.9M | 0.03% |
250,960
-25,659
| -9% | -$7.66M |
|
445
McCormick & Company Non-Voting
MKC
$18.8B
| $74.2M | 0.03% |
832,263
-10,646
| -1% | -$949K |
|
446
American International
AIG
$45.3B
| $74.2M | 0.03% |
1,605,428
+582,145
| +57% | +$26.9M |
|
447
Entergy
ETR
$39.4B
| $74.2M | 0.03% |
1,490,944
-238,178
| -14% | -$11.8M |
|
448
Openlane
KAR
$3.1B
| $74M | 0.03% |
4,935,384
+3,150,931
| +177% | +$47.3M |
|
449
Phathom Pharmaceuticals
PHAT
$851M
| $73.4M | 0.03% |
1,954,448
+16,012
| +0.8% | +$601K |
|
450
Colgate-Palmolive
CL
$67.6B
| $73.3M | 0.03% |
929,333
-50,537
| -5% | -$3.98M |
|